Microdosing is a dosing strategy, not a way to get around qualification requirements
For Merck, this collaboration adds more "chips" to its GLP-1 portfolio and may also serve as a potential successor to Keytrudas market dominance
doi: 10.3390/ijms25042009 55
the adverse side effects of these anticancer drugs highlight the need for the development of new therapies selective for pathogenic cell populations and with reduced host toxicity
In the late nineteenth century, the psychologist and philosopher William James wrote, If the word sacred can be applied to any personal right, surely the right to treat ones own body as one chooses may claim this title. A few years later, the Postmaster General stopped delivering mail to the American School of Magnetic Healing, arguing that the organization was committing medical fraud
In a future TNG post, contributing writer MacKenzie Isaac, a doctoral student in population health, will cover equity issues surrounding GLP-1 RA access